VATH

None

A synthetic androgenic anabolic steroid used in the treatment of male hypogonadism and in the palliative therapy of inoperable female breast cancer in selected patients, administered orally.

This drug should be coded

None

None

Cell cycle nonspecific chemotherapeutic agent. FDA approved uses on intravesicular bladder carcinoma, breast adenocarcinoma, malignant intracavitary effusions, Hodgkin's lymphoma, lymphosarcoma, and ovarian adenocarcinoma. Alkylating agent.

This drug should be coded

None

Phase II liver, pancreatic, Phase III MM, prostate Doxorubicin hydrochloride encapsulated in liposomes formulated with methoxypolyethylene glycol (MPEG). FDA approved use on bladder cancer, breast cancer, gastric cancer, leukemia, small cell lung cancer, lymphoma, neuroblastoma, ovarian cancer, sarcoma, thyroid cancer, Wilm's tumor. ALZA Corp, NeoPharm, Pharmacia, Schering-Plough, Sequus. Antitumor antibiotic

This drug should be coded

None

None

A cell cycle specific chemotherapeutic agent; vinca plant alkaloid; mitotic inhibitor. FDA approved uses in 3rd line breast cancer, choriocarcinoma, palliative in stages III and IV Hodgkin's lymphoma, Kaposi's sarcoma, mycosis fungoides, palliative in non-Hodgkin's histiocytic/lymphocytic lymphoma, and advanced testicular carcinoma.

This drug should be coded